Randomized, Single-blinded, Multicenter Trial Comparing the Immune Response to a 2nd Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNTech) or Sanofi /GSK B.1.351 Adjuvanted Vaccine in Adults

NCT05405283 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

189

Enrollment

OTHER

Sponsor class

Conditions

COVID-19 Vaccines

Interventions

BIOLOGICAL: 2nd booster with Comirnaty® (Pfizer-BioNTech)
BIOLOGICAL: CoV2 preS dTM adjuvanted vaccine (B.1.351), Sanofi/GSK

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]